The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,698,915 in first-year total cost, median $442,500.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMM-K (52)]8
- Special Emphasis Panel[ZRG1-IMM-K(52)]1
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL3
- CHILDREN'S HOSP OF PHILADELPHIA1
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- NATIONAL JEWISH HEALTH1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD1R01AI141389-01 | BRATTON, DONNA LHENSON, PETER M | NATIONAL JEWISH HEALTH, CO | $622,106 | ZRG1 |
| 2018 | CRAC Channel Deficiency in Immunity to Infection2R01AI097302-06 | FESKE, STEFAN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $536,208 | ZRG1 |
| 2018 | Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG11R01AI139633-01 | GEHA, RAIF SALIM | BOSTON CHILDREN'S HOSPITAL, MA | $442,500 | ZRG1 |
| 2017 | Mechanisms of Disease Pathogenesis in Regulatory T cell Deficiency2R01AI085090-07A1 | CHATILA, TALAL AMINEWILLIAMS, CALVIN B | BOSTON CHILDREN'S HOSPITAL, MA | $448,598 | ZRG1 |
| 2017 | Role of Stx11 and STXBP2 in lytic granule exocytosis in health and disease1R01AI123538-01A1 | GIRAUDO, CLAUDIO GUILLERMO | CHILDREN'S HOSP OF PHILADELPHIA, PA | $435,760 | ZRG1 |
| 2017 | Genome-wide search for inborn errors of IL-17 immunity underlying chronic mucocutaneous candidiasis1R01AI127564-01 | CASANOVA, JEAN-LAURENT | ROCKEFELLER UNIVERSITY, NY | $423,750 | ZRG1 |
| 2017 | Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies1R01AI127372-01A1 | BOGUNOVIC, DUSAN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $423,750 | ZRG1 |
| 2017 | Employing novel humanized murine strains to develop hematopoietic stem cell gene therapeutic approaches for very early-onset inflammatory bowel disease due to IL10-receptor deficiency.1R56AI125766-01A1 | SNAPPER, SCOTT BWILLIAMS, DAVID A | BOSTON CHILDREN'S HOSPITAL, MA | $407,902 | ZRG1 |
| 2016 | Multiplexed immuno-SRM screening for primary immunodeficiencies1R01AI123135-01 | HAHN, SIHOUN | SEATTLE CHILDREN'S HOSPITAL, WA | $958,341 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.